HeartBeam Expands Concierge Cardiology Footprint With Atelier Health Agreement

HeartBeam Inc. (NASDAQ: BEAT), a medical technology company specializing in cardiac care solutions, announced a commercial agreement with Atelier Health, a concierge medical practice based in Beverly Hills, California. This partnership expands HeartBeam's launch footprint into Southern California and completes its initial targeted markets, which also include the New York metro area, Dallas, and South Florida. The agreement advances the commercialization of HeartBeam's cable-free 3D ECG technology, designed for remote cardiac monitoring and preventive cardiology.

HeartBeam is creating the first-ever cable-free device capable of collecting ECG signals in three dimensions from three non-coplanar directions and synthesizing them into a 12-lead ECG. This platform technology is intended for portable devices that can be used wherever the patient is located, delivering actionable heart intelligence. Physicians can identify cardiac health trends and acute conditions and direct patients to appropriate care outside of a medical facility. The technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-lead ECG synthesis software received clearance in December 2025. The company holds over 20 issued patents related to its technology.

The expansion into Southern California through the Atelier Health agreement marks a significant step in HeartBeam's commercialization strategy. By partnering with a concierge medical practice, HeartBeam aims to provide its advanced remote monitoring capabilities to a patient population that values personalized and accessible healthcare. The agreement is expected to facilitate the adoption of HeartBeam's technology among cardiologists and patients seeking innovative cardiac care solutions.

Atelier Health is a concierge medical practice that offers personalized healthcare services to its members. By integrating HeartBeam's 3D ECG technology, Atelier Health can offer remote cardiac monitoring, allowing for continuous assessment of patients' heart health without the need for frequent in-office visits. This aligns with the growing trend toward remote patient monitoring and preventive medicine.

The completion of HeartBeam's initial targeted markets positions the company for broader commercialization efforts. The company's technology has the potential to transform cardiac care by enabling early detection of arrhythmias and other cardiac conditions, ultimately improving patient outcomes. For more information on HeartBeam's cleared indications for use, visit https://www.heartbeam.com/indications.

This announcement is important as it demonstrates HeartBeam's progress in bringing its innovative technology to market. The partnership with Atelier Health not only expands the company's geographic reach but also validates the demand for remote cardiac monitoring solutions among concierge medical practices. As HeartBeam continues to commercialize its technology, it may play a key role in reshaping how cardiac care is delivered, moving from hospital-based to patient-centered care.